IHIren Drange Hjellestad

Iren Drange Hjellestad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iren Drange Hjellestad has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Eirik Søfteland

    Department of Laboratory Medicine and Pathology, Hormone Laboratory, Haukeland University Hospital, Bergen, Norway

    3 shared publications
  • Torbjørn Jonung

    Department of Clinical Sciences, University of Bergen, Bergen, Norway

    2 shared publications
  • B. H. Wold

    Department of Vascular Surgery, Nordland Hospital Trust Bodø, Bodø, Norway

    1 shared publication
  • C. Lyng

    Department of Vascular Surgery, Innlandet Hospital Trust Hamar, Hamar, Norway

    1 shared publication
  • E. M. Pettersen

    Department of Circulation and Medical Imaging, NTNU- Norwegian University of Science and Technology, Trondheim, Norway

    1 shared publication
  • E. Mattsson

    Department of Circulation and Medical Imaging, NTNU- Norwegian University of Science and Technology, Trondheim, Norway

    1 shared publication

Latest Publications

  • Open Access

    High proportion of undiagnosed diabetes in patients surgically treated for infrarenal abdominal aortic aneurysm: findings from the multicentre Norwegian Aortic Aneurysm and Diabetes (ABANDIA) Study

    by J. Wesche, T. Bakken, M. Vetrhus, K. O. Hufthammer, L. Aa Nyroenning, H. Fagertun, I. Saethre, B. H. Wold, C. Lyng, E. M. Pettersen, et al.

    The aim was to investigate the total prevalence of known and undiagnosed diabetes mellitus (DM), and the association of DM with perioperative complications following elective, infrarenal, open surgical (OSR) or endovascular (EVAR), Abdominal Aortic Aneurysm (AAA) repair. In this Norwegian prospective multicentre study, 877 patients underwent preoperative screening for DM by HbA1c measurements from November 2017 to December 2020. Diabetes was defined as screening detected HbA1c ≥ 48 mmol/mol (6.5%) or previously diagnosed diabetes. The association of DM with in-hospital complications, length of stay, and 30-day mortality rate were evaluated using adjusted and unadjusted logistic regression models. The total prevalence of DM was 15% (95% CI 13%,17%), of which 25% of the DM cases (95% CI 18%,33%) were undiagnosed upon admission for AAA surgery. The OSR to EVAR ratio was 52% versus 48%, with similar distribution among DM patients, and no differences in the prevalence of known and undiagnosed DM in the EVAR versus the OSR group. Total 30-day mortality rate was 0.6% (5/877). Sixty-six organ-related complications occurred in 58 (7%) of the patients. DM was not statistically significantly associated with a higher risk of in-hospital organ-related complications (OR 1.23, 95% CI 0.57,2.39, p = 0.57), procedure-related complications (OR 1.48, 95% CI 0.79,2.63, p = 0.20), 30-day mortality (p = 0.09) or length of stay (HR 1.06, 95% CI 0.88,1.28, p = 0.54). According to post-hoc-analyses, organ-related complications were more frequent in patients with newly diagnosed DM (n = 32) than in non-DM patients (OR 4.92; 95% CI 1.53,14.3, p = 0.005). Twenty-five percent of all DM cases were undiagnosed at the time of AAA surgery. Based on post-hoc analyses, undiagnosed DM seems to be associated with an increased risk of organ related complications following AAA surgery. This study suggests universal DM screening in AAA patients to reduce the number of DM patients being undiagnosed and to improve proactive diabetes care in this population. The results from post-hoc analyses should be confirmed in future studies.


  • HbA1c predicts long‐term postoperative mortality in patients with unknown glycemic status at admission for vascular surgery: An exploratory study

    by Iren Drange Hjellestad, Eirik Søfteland, Eystein S. Husebye, Torbjørn Jonung

    Background: Peripheral arterial disease (PAD) and diabetes mellitus (DM) represent major public health challenges and are tightly associated. To facilitate early diagnosis, HbA1c has been implemented as the preferred diagnostic tool for the diagnosis of type 2 DM. In this study, we compared and evaluated HbA1c, fasting plasma glucose (FPG), and 2‐hour post‐load glucose values to determine which test best predicted mortality in patients with PAD.Methods: In all, 273 PAD patients with unknown glycemic status admitted to Haukeland University Hospital for elective surgery between October 2006 and September 2007 were included in the study. All 273 patients underwent a standard oral glucose tolerance test (OGTT) in addition to determination of HbA1c; patients were then grouped into those with DM, intermediate hyperglycemia, and normoglycemia according to World Health Organization and International Expert Committee criteria.Results: All‐cause mortality was 40% over a 9‐year follow‐up period. After adjusting for age, sex, and relevant medication, HbA1c was a predictor for mortality (hazard ratio [HR] 1.54; 95% confidence interval [CI] 1.03‐2.32]; P = 0.04). The association did not achieve statistical significance in a fully adjusted Cox regression model, although the effect estimation of HbA1c on all‐cause mortality remained largely unchanged (HR 1.39; 95% CI 0.92‐2.09; P = 0.13). The OGTT was not a predictor of long‐term mortality.Conclusions: The results indicate that HbA1c is a useful marker in the preoperative screening of patients of unknown glycemic status at the time of admission for vascular surgery, and may identify people at high risk of long‐term mortality following surgical treatment for PAD.


  • Open Access

    Correction to: HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients

    by Iren D. Hjellestad, Marianne C. Astor, Roy M. Nilsen, Eirik Søfteland, Torbjørn Jonung

    The authors found errors in Table 1 after publication of the original article [1]. The correct values for medical history of coronary artery disease (CAD) at baseline are 110 (40%) of all patients, 54 (35.5%) of patients categorized as having normoglycaemia, 42 (46.7%) of patients categorized as having intermediate hyperglycaemia, and 14 (42.4%) of patients categorized as having DM. All presented numbers and calculations in Table 1 are checked. No other errors were found. The presented errors did not affect results, scientific content or conclusions. The corrected Table 1 is presented in this erratum. The authors apologize for having presented this error in the original article.


  • Abdominal aortic aneurysms – glycaemic status and mortality

    by Iren Drange Hjellestad, Eirik Søfteland, Roy Miodini Nilsen, Eystein Sverre Husebye, Torbjørn Jonung


  • Open Access

    HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients

    by Iren D Hjellestad, Marianne C Astor, Roy M Nilsen, Eirik Søfteland, Torbjørn Jonung

    The diagnosis of diabetes mellitus (DM) is based on either fasting plasma glucose levels or an oral glucose tolerance test (OGTT). Recently, an HbA1c value of ≥ 48 mmol/mol (6.5%) has been included as an additional test to diagnose DM. The purpose of this study was to validate HbA1c versus OGTT as a method to diagnose DM in vascular surgery patients.